跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 32,533 条关于
“TARGET Protein”
全部
32,533
临床试验
17,092
药物
1,830
机构
109
资讯
13,502
23天前
Computer Model Could Streamline Design of Protein-Degrading Cancer Therapies
去年
Novartis Licenses Monte Rosa's Molecular Glue Degrader for Autoimmune Diseases
去年
Halda Therapeutics to Present RIPTAC Cancer Therapies at J.P. Morgan Healthcare Conference
6个月前
HYDRACs: Protein-Like Polymers Open New Frontier in Targeted Protein Degradation for Undruggable Cancer Targets
去年
Amphista Therapeutics Advances Novel BRD9 Degraders Using Proprietary Targeted Glue Technology
去年
Novel PROTAC Degrader ACBI3 Shows Efficacy Against Multiple KRAS Mutant Cancers
8个月前
Breakthrough in Protein Degradation Technology Reveals Molecular Mechanisms for Targeting 'Undruggable' Diseases
去年
Novartis and Monte Rosa Therapeutics Partner to Advance VAV1 Molecular Glue Degrader
去年
Agilent and Ubix Therapeutics Form 5-Year Partnership to Advance Targeted Cancer Therapies in South Korea
27天前
Orum Therapeutics Announces U.S. FDA Clearance of IND for ORM-1153, a First-in-Class CD123-GSPT1 Degrader-Antibody Conjugate
第 1 页,共 1351 页
上一页
下一页